← back to search

Hong Bu

Qingdao University of Science and Technology · CN
Area of research
Cancer Research · Artificial Intelligence
Research interest
Research interests include Breast Cancer Treatment Studies, AI in cancer detection, Radiomics and Machine Learning in Medical Imaging, and HER2/EGFR in Cancer Research.
h-index
46
citations
7,414
works
338
NIH funding
primary concept
email

Recent publications

Chinese guidelines for HER2 testing in breast cancer (2024 edition): summary of key recommendations
Journal of Clinical Pathology 2025cited by 0position: middledoi
A Study on Automatic O-RADS Classification of Sonograms of Ovarian Adnexal Lesions Based on Deep Convolutional Neural Networks
Ultrasound in Medicine & Biology 2024cited by 4position: middledoi
<b>Experts' </b><b>C</b><b>ognition-Driven Ensemble Deep Learning </b><b>f</b><b>or External Validation of Predicting Pathological Complete Response to Neoadjuvant Chemotherapy </b><b>f</b><b>rom Histological Images in Breast Cancer</b>
Medinformatics 2024cited by 4position: lastdoi
Exploratory study on the enhancement of O-RADS application effectiveness for novice ultrasonographers via deep learning
Archives of Gynecology and Obstetrics 2024cited by 3position: middledoi
Combining the tumor-stroma ratio with tumor-infiltrating lymphocytes improves the prediction of pathological complete response in breast cancer patients
Breast Cancer Research and Treatment 2023cited by 10position: lastdoi
Near-Infrared II Hyperspectral Imaging Improves the Accuracy of Pathological Sampling of Multiple Cancer Types
Laboratory Investigation 2023cited by 4position: middledoi
336P Dual-mode near-infrared multispectral imaging system equipped with deep learning models improves the identification of cancer foci in breast cancer specimens
Annals of Oncology 2023cited by 3position: middledoi
ERBB2 mRNA expression to distinguish HER2-low/neg breast cancer prognosis.
Journal of Clinical Oncology 2023cited by 2position: lastdoi
Dual-mode near-infrared multispectral imaging system equipped with deep learning models improves the identification of cancer foci in breast cancer specimens
Research Square 2023cited by 0position: middledoi
CACA Guidelines for Holistic Integrative Management of Breast Cancer
Holistic Integrative Oncology 2022cited by 57position: middledoi
Predicting neoadjuvant chemotherapy benefit using deep learning from stromal histology in breast cancer
npj Breast Cancer 2022cited by 31position: lastdoi
Dual-mode near-infrared multispectral imaging system equipped with deep learning models improves the identification of cancer foci in breast cancer specimens
medRxiv 2022cited by 0position: middledoi
Near-infrared II hyperspectral imaging improves the accuracy of pathological sampling of multiple cancer specimens
medRxiv 2022cited by 0position: middledoi
How can artificial intelligence models assist PD-L1 expression scoring in breast cancer: results of multi-institutional ring studies
npj Breast Cancer 2021cited by 41position: middledoi
Improving Ki67 assessment concordance by the use of an artificial intelligence‐empowered microscope: a multi‐institutional ring study
Histopathology 2021cited by 24position: middledoi
Accurate Prognostic Prediction for Breast Cancer Based on Histopathological Images by Artificial Intelligence
SSRN Electronic Journal 2021cited by 0position: lastdoi
Prediction model of the response to neoadjuvant chemotherapy in breast cancers by a Naive Bayes algorithm
Computer Methods and Programs in Biomedicine 2020cited by 30position: lastdoi
Blind deblurring for microscopic pathology images using deep learning networks
arXiv (Cornell University) 2020cited by 6position: middledoi
[Research progress of biomarkers in breast phyllodes tumours].
PubMed 2020cited by 1position: lastdoi
Efficacy and safety of oral poly (ADP-ribose) polymerase inhibitor fluzoparib in patients with BRCA1/2 mutations and recurrent ovarian cancer
Gynecologic Oncology 2020cited by 0position: middledoi
Immune Profiles of Tumor Microenvironment and Clinical Prognosis among Women with Triple-Negative Breast Cancer
Cancer Epidemiology Biomarkers & Prevention 2019cited by 58position: middledoi
Somatic alterations of <i>TP53</i>,<i> ERBB2</i>,<i> PIK3CA</i> and <i>CCND1</i> are associated with chemosensitivity for breast cancers
Cancer Science 2019cited by 46position: lastdoi
Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Detection in Invasive Breast Carcinoma: A Retrospective Study of 12,467 Patients From 19 Chinese Representative Clinical Centers
Clinical Breast Cancer 2019cited by 39position: middledoi
Repression of miR-135b-5p promotes metastasis of early-stage breast cancer by regulating downstream target SDCBP
Laboratory Investigation 2019cited by 24position: lastdoi
Screening of Recurrence Related MicroRNA in Ductal Carcinoma <i>In Situ</i> and Functional Study of MicroRNA-654-5p
Journal of Breast Cancer 2019cited by 7position: lastdoi
Tamoxifen enhances stemness and promotes metastasis of ERα36+ breast cancer by upregulating ALDH1A1 in cancer cells
Cell Research 2018cited by 129position: middledoi
Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non‐medullary thyroid carcinoma
International Journal of Cancer 2018cited by 48position: lastdoi
Long term prognosis of ductal carcinoma <i>in situ</i> with microinvasion: a retrospective cohort study.
PubMed 2018cited by 20position: last
A decision tree-based prediction model for fluorescence <i>in situ</i> hybridization <i>HER2</i> gene status in HER2 immunohistochemistry-2+ breast cancers: a 2538-case multicenter study on consecutive surgical specimens
Journal of Cancer 2018cited by 8position: middledoi
Senescence of mesenchymal stem cells (Review)
International Journal of Molecular Medicine 2017cited by 297position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yueping Liu · Hebei Medical University17 papers (2018–2023)Jianhua Yao · Trine University7 papers (2020–2023)Dandan Han · University of Science and Technology of China5 papers (2021–2023)Zhanli Jia · Hebei Medical University5 papers (2021–2023)Jun Liao · University of Connecticut5 papers (2020–2023)Shuyao Niu · Hebei Medical University5 papers (2021–2023)Xiao Lin · Anhui Medical University4 papers (2018–2020)Libo Yang · South China University of Technology4 papers (2018–2020)Chenchen Qin · Anhui University4 papers (2022–2023)Meng Zhang · Second Affiliated Hospital of Nanchang University4 papers (2022–2023)Hong Zheng · South China Agricultural University4 papers (2018–2021) · 3 papers (2018–2019)Yani Wei · The First Affiliated Hospital, Sun Yat-sen University3 papers (2022–2024)Wentao Yang · Theranostics (New Zealand)3 papers (2019–2025)Yuanyuan Zhao · Shanxi Medical University3 papers (2022–2024)Xiaorong Zhong · Nantong University3 papers (2018–2021)Bo Fu · University of Electronic Science and Technology of China3 papers (2018–2021)Hong‐Wei Gao · South China Agricultural University3 papers (2018–2019)Feng Ye · Sichuan University3 papers (2018–2020)Jing Fu · Xinjiang University3 papers (2022–2024)